메뉴 건너뛰기




Volumn 33, Issue SUPPL. 1, 2009, Pages

The hypercoagulable state in thalassemia intermedia

Author keywords

Hypercoagulability; Review; Thalassemia intermedia; Thrombosis

Indexed keywords

CD63 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROXYUREA; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE PROTEIN; PADGEM PROTEIN; PROCOAGULANT; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE; THROMBOXANE A2; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

EID: 73949099713     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630260903351619     Document Type: Conference Paper
Times cited : (16)

References (57)
  • 1
    • 0031872838 scopus 로고    scopus 로고
    • Relationship between genotype and phenotype: Thalassemia intermedia
    • Galanello R, Cao A. Relationship between genotype and phenotype. Thalassemia intermedia. Ann NY Acad Sci. 1998;850:325-333. (Pubitemid 128714088)
    • (1998) Annals of the New York Academy of Sciences , vol.850 , pp. 325-333
    • Galanello, R.1    Cao, A.2
  • 2
    • 0029279125 scopus 로고
    • The molecular basis for phenotypic variability of the common thalassaemias
    • Weatherall D. The molecular basis for phenotypic variability of the common thalassaemias. Mol Med Today. 1995;1:15-20.
    • (1995) Mol Med Today , vol.1 , pp. 15-20
    • Weatherall, D.1
  • 4
    • 0033536288 scopus 로고    scopus 로고
    • The beta-thalassemias
    • Olivieri NF. The beta-thalassemias. N Engl J Med. 1999;341:99-109.
    • (1999) N Engl J Med , vol.341 , pp. 99-109
    • Olivieri, N.F.1
  • 6
    • 0036069008 scopus 로고    scopus 로고
    • Pulmonary thromboembolism in beta-thalassemia intermedia: Are we aware of this complication?
    • Taher A, Abou-Mourad Y, Abchee A, Zallouaa P, Shamseddine A. Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication? Hemoglobin. 2002;26:107-112.
    • (2002) Hemoglobin , vol.26 , pp. 107-112
    • Taher, A.1    Abou-Mourad, Y.2    Abchee, A.3    Zallouaa, P.4    Shamseddine, A.5
  • 9
    • 0031440087 scopus 로고    scopus 로고
    • Pseudoxanthoma elasticum lesions and cardiac complications as contributing factors for strokes in betathalassemia patients
    • Aessopos A, Farmakis D, Karagiorga M, Rombos I, Loucopoulos D. Pseudoxanthoma elasticum lesions and cardiac complications as contributing factors for strokes in betathalassemia patients. Stroke. 1997;28:2421-2424.
    • (1997) Stroke , vol.28 , pp. 2421-2424
    • Aessopos, A.1    Farmakis, D.2    Karagiorga, M.3    Rombos, I.4    Loucopoulos, D.5
  • 11
    • 0031930888 scopus 로고    scopus 로고
    • Thromboembolic events in beta thalassemia major: An Italian multicenter study
    • Borgna Pignatti C, Carnelli V, Caruso V, et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol. 1998;99:76-79.
    • (1998) Acta Haematol , vol.99 , pp. 76-79
    • Borgna Pignatti, C.1    Carnelli, V.2    Caruso, V.3
  • 13
    • 33749872392 scopus 로고    scopus 로고
    • Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran
    • Taher A, Isma'eel H, Mehio G, et al. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost. 2006;96:488-491.
    • (2006) Thromb Haemost , vol.96 , pp. 488-491
    • Taher, A.1    Isma'Eel, H.2    Mehio, G.3
  • 14
    • 0024337363 scopus 로고
    • Survival and causes of death in thalassaemia major
    • Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989;2:27-30.
    • (1989) Lancet , vol.2 , pp. 27-30
    • Zurlo, M.G.1    De Stefano, P.2    Borgna-Pignatti, C.3
  • 15
    • 20844460608 scopus 로고    scopus 로고
    • Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine
    • Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89: 1187-1193.
    • (2004) Haematologica , vol.89 , pp. 1187-1193
    • Borgna-Pignatti, C.1    Rugolotto, S.2    De Stefano, P.3
  • 16
    • 0032697251 scopus 로고    scopus 로고
    • MR imaging of the brain: Findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease
    • Manfre L, Giarratano E, Maggio A, Banco A, Vaccaro G, Lagalla R. MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. AJR Am J Roentgenol. 1999;173:1477-1480.
    • (1999) AJR Am J Roentgenol , vol.173 , pp. 1477-1480
    • Manfre, L.1    Giarratano, E.2    Maggio, A.3    Banco, A.4    Vaccaro, G.5    Lagalla, R.6
  • 17
    • 0015307314 scopus 로고
    • Thalassemia major (homozygous betathalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects
    • Logothetis J, Constantoulakis M, Economidou J, et al. Thalassemia major (homozygous betathalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology. 1972;22:294-304.
    • (1972) Neurology , vol.22 , pp. 294-304
    • Logothetis, J.1    Constantoulakis, M.2    Economidou, J.3
  • 22
    • 0036092892 scopus 로고    scopus 로고
    • The hypercoagulable state in thalassemia
    • Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood. 2002;99:36-43.
    • (2002) Blood , vol.99 , pp. 36-43
    • Eldor, A.1    Rachmilewitz, E.A.2
  • 24
    • 34548585444 scopus 로고    scopus 로고
    • Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability
    • Ataga KI, Cappellini MD, Rachmilewitz EA. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. Br J Haematol. 2007;139:3-13.
    • (2007) Br J Haematol , vol.139 , pp. 3-13
    • Ataga, K.I.1    Cappellini, M.D.2    Rachmilewitz, E.A.3
  • 27
    • 0030751208 scopus 로고    scopus 로고
    • In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major
    • Ruf A, Pick M, Deutsch V, et al. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol. 1997;98:51-56.
    • (1997) Br J Haematol , vol.98 , pp. 51-56
    • Ruf, A.1    Pick, M.2    Deutsch, V.3
  • 28
    • 0024428305 scopus 로고
    • Platelet survival in patients with beta-thalassemia
    • Eldor A, Krausz Y, Atlan H, et al. Platelet survival in patients with beta-thalassemia. Am J Hematol. 1989;32:94-99.
    • (1989) Am J Hematol , vol.32 , pp. 94-99
    • Eldor, A.1    Krausz, Y.2    Atlan, H.3
  • 29
    • 0025893846 scopus 로고
    • In vivo platelet activation in betathalassemia major reflected by increased platelet-thromboxane urinary metabolites
    • Eldor A, Lellouche F, Goldfarb A, Rachmilewitz EA, Maclouf J. In vivo platelet activation in betathalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood. 1991;77: 1749-1753.
    • (1991) Blood , vol.77 , pp. 1749-1753
    • Eldor, A.1    Lellouche, F.2    Goldfarb, A.3    Rachmilewitz, E.A.4    MacLouf, J.5
  • 31
    • 0024560085 scopus 로고
    • Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia
    • Shinar E, Rachmilewitz EA, Lux SE. Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. J Clin Invest. 1989;83:404-410.
    • (1989) J Clin Invest , vol.83 , pp. 404-410
    • Shinar, E.1    Rachmilewitz, E.A.2    Lux, S.E.3
  • 32
    • 0018164919 scopus 로고
    • Nonspecific serum iron in thalassaemia: An abnormal serum iron fraction of potential toxicity
    • Hershko C, Graham G, Bates GW, Rachmilewitz EA. Nonspecific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol. 1978;40:255-263.
    • (1978) Br J Haematol , vol.40 , pp. 255-263
    • Hershko, C.1    Graham, G.2    Bates, G.W.3    Rachmilewitz, E.A.4
  • 33
    • 5444273795 scopus 로고    scopus 로고
    • The role of phosphatidylserine in recognition and removal of erythrocytes
    • Kuypers FA, de Jong K. The role of phosphatidylserine in recognition and removal of erythrocytes. Cell Mol Biol (Noisy-le-grand). 2004;50:147-158.
    • (2004) Cell Mol Biol (Noisy-le-grand) , vol.50 , pp. 147-158
    • Kuypers, F.A.1    De Jong, K.2
  • 34
    • 0035134808 scopus 로고    scopus 로고
    • Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes
    • Tavazzi D, Duca L, Graziadei G, Comino A, Fiorelli G, Cappellini MD. Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes. Br J Haematol. 2001; 112:48-50.
    • (2001) Br J Haematol , vol.112 , pp. 48-50
    • Tavazzi, D.1    Duca, L.2    Graziadei, G.3    Comino, A.4    Fiorelli, G.5    Cappellini, M.D.6
  • 35
    • 0027161045 scopus 로고
    • Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes
    • Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol. 1993;44:63-65.
    • (1993) Am J Hematol , vol.44 , pp. 63-65
    • Borenstain-Ben Yashar, V.1    Barenholz, Y.2    Hy-Am, E.3    Rachmilewitz, E.A.4    Eldor, A.5
  • 36
    • 0029853276 scopus 로고    scopus 로고
    • Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and betathalassemia
    • Helley D, Eldor A, Girot R, Ducrocq R, Guillin MC, Bezeaud A. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and betathalassemia. Thromb Haemost. 1996;76:322-327.
    • (1996) Thromb Haemost , vol.76 , pp. 322-327
    • Helley, D.1    Eldor, A.2    Girot, R.3    Ducrocq, R.4    Guillin, M.C.5    Bezeaud, A.6
  • 37
    • 0036039730 scopus 로고    scopus 로고
    • Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta thalassaemic patients
    • Atichartakarn V, Angchaisuksiri P, Aryurachai K, et al. Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta thalassaemic patients. Br J Haematol. 2002;118:893-898.
    • (2002) Br J Haematol , vol.118 , pp. 893-898
    • Atichartakarn, V.1    Angchaisuksiri, P.2    Aryurachai, K.3
  • 38
    • 33750828453 scopus 로고    scopus 로고
    • Enhanced aggregability of red blood cells of beta-thalassemia major patients
    • Chen S, Eldor A, Barshtein G, et al. Enhanced aggregability of red blood cells of beta-thalassemia major patients. Am J Physiol. 1996;270:H1951-H1956.
    • (1996) Am J Physiol , vol.270
    • Chen, S.1    Eldor, A.2    Barshtein, G.3
  • 39
    • 0028806566 scopus 로고
    • Alterations in vascular endothelial cellrelated plasma proteins in thalassaemic patients and their correlation with clinical symptoms
    • Butthep P, Bunyaratvej A, Funahara Y, et al. Alterations in vascular endothelial cellrelated plasma proteins in thalassaemic patients and their correlation with clinical symptoms. Thromb Haemost. 1995;74:1045-1049.
    • (1995) Thromb Haemost , vol.74 , pp. 1045-1049
    • Butthep, P.1    Bunyaratvej, A.2    Funahara, Y.3
  • 40
    • 0031301075 scopus 로고    scopus 로고
    • Possible evidence of endothelial cell activation and disturbance in thalassemia: An in vitro study
    • Butthep P, Bunyaratvej A, Funahara Y, et al. Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study. Southeast Asian J Trop Med Public Health. 1997;28 (Suppl. 3):141A-148A.
    • (1997) Southeast Asian J Trop Med Public Health , vol.28 , Issue.SUPPL. 3
    • Butthep, P.1    Bunyaratvej, A.2    Funahara, Y.3
  • 41
    • 0032818059 scopus 로고    scopus 로고
    • Enhanced adherence of beta-thalassaemic erythrocytes to endothelial cells
    • Hovav T, Goldfarb A, Artmann G, Yedgar S, Barshtein G. Enhanced adherence of beta-thalassaemic erythrocytes to endothelial cells. Br J Haematol. 1999;106:178-181.
    • (1999) Br J Haematol , vol.106 , pp. 178-181
    • Hovav, T.1    Goldfarb, A.2    Artmann, G.3    Yedgar, S.4    Barshtein, G.5
  • 42
    • 0036105903 scopus 로고    scopus 로고
    • Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia
    • Butthep P, Rummavas S, Wisedpanichkij R, Jindadamrongwech S, Fucharoen S, Bunyaratvej A. Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. Am J Hematol. 2002;70:100-106.
    • (2002) Am J Hematol , vol.70 , pp. 100-106
    • Butthep, P.1    Rummavas, S.2    Wisedpanichkij, R.3    Jindadamrongwech, S.4    Fucharoen, S.5    Bunyaratvej, A.6
  • 43
    • 0027935309 scopus 로고
    • Leukocyte-endothelial adhesion molecules
    • Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.
    • (1994) Blood , vol.84 , pp. 2068-2101
    • Carlos, T.M.1    Harlan, J.M.2
  • 45
    • 44949126303 scopus 로고    scopus 로고
    • Elevated levels of circulating procoagulant microparticles in patients with b-thalassemia Intermedia
    • Habib A, Kunzelmann C, Shamseddeen W, Zobairi F, Freyssinet JM, Taher A. Elevated levels of circulating procoagulant microparticles in patients with b-thalassemia Intermedia. Haematologica. 2008;93:941-942.
    • (2008) Haematologica , vol.93 , pp. 941-942
    • Habib, A.1    Kunzelmann, C.2    Shamseddeen, W.3    Zobairi, F.4    Freyssinet, J.M.5    Taher, A.6
  • 47
    • 0141680833 scopus 로고    scopus 로고
    • In vivo platelet activation and hyperaggregation in hemoglobin E/beta-thalassemia: A consequence of splenectomy
    • Atichartakarn V, Angchaisuksiri P, Aryurachai K, Chuncharunee S, Thakkinstian A. In vivo platelet activation and hyperaggregation in hemoglobin E/beta-thalassemia: a consequence of splenectomy. Int J Hematol. 2003;77:299-303.
    • (2003) Int J Hematol , vol.77 , pp. 299-303
    • Atichartakarn, V.1    Angchaisuksiri, P.2    Aryurachai, K.3    Chuncharunee, S.4    Thakkinstian, A.5
  • 48
    • 1642462251 scopus 로고    scopus 로고
    • Incidence of thromboembolic events in Lebanese thalassemia intermedia patients
    • Zalloua PA, Shbaklo H, Mourad YA, Koussa S, Taher A. Incidence of thromboembolic events in Lebanese thalassemia intermedia patients. Thromb Haemost. 2003;89:767-768.
    • (2003) Thromb Haemost , vol.89 , pp. 767-768
    • Zalloua, P.A.1    Shbaklo, H.2    Mourad, Y.A.3    Koussa, S.4    Taher, A.5
  • 49
    • 0034756542 scopus 로고    scopus 로고
    • Thrombophilia in thalassemia major patients: Analysis of genetic predisposing factors
    • Iolascon A, Giordano P, Storelli S, et al. Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors. Haematologica. 2001;86:1112-1113.
    • (2001) Haematologica , vol.86 , pp. 1112-1113
    • Iolascon, A.1    Giordano, P.2    Storelli, S.3
  • 50
    • 0031658928 scopus 로고    scopus 로고
    • Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia
    • Giordano P, Galli M, Del Vecchio GC, et al. Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia. Br J Haematol. 1998;102:903-906.
    • (1998) Br J Haematol , vol.102 , pp. 903-906
    • Giordano, P.1    Galli, M.2    Del Vecchio, G.C.3
  • 51
    • 10744231450 scopus 로고    scopus 로고
    • Effects of 5-aza-2¢-deoxycytidine on fetal haemoglobin levels, red cell adhesion, and haematopoietic differentiation in patients with sickle cell disease
    • Saunthararajah Y, Hillery CA, Lavelle D, et al. Effects of 5-aza-2¢-deoxycytidine on fetal haemoglobin levels, red cell adhesion, and haematopoietic differentiation in patients with sickle cell disease. Blood. 2003;102:3865-3870.
    • (2003) Blood , vol.102 , pp. 3865-3870
    • Saunthararajah, Y.1    Hillery, C.A.2    Lavelle, D.3
  • 52
    • 2942720403 scopus 로고    scopus 로고
    • Effects of hydroxyurea on the membrane of erythrocytes and platelets in the sickle cell anaemia
    • Covas DT, Angulo I, Palma PVB, Zago MA. Effects of hydroxyurea on the membrane of erythrocytes and platelets in the sickle cell anaemia. Haematologica. 2004;89:273-280.
    • (2004) Haematologica , vol.89 , pp. 273-280
    • Covas, D.T.1    Angulo, I.2    Palma, P.V.B.3    Zago, M.A.4
  • 53
    • 0034082976 scopus 로고    scopus 로고
    • Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin
    • Hillery CA, Du MC, Wang WC, Scott JP. Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin. Br J Haematol. 2000;109:322-327.
    • (2000) Br J Haematol , vol.109 , pp. 322-327
    • Hillery, C.A.1    Du, M.C.2    Wang, W.C.3    Scott, J.P.4
  • 54
    • 0032977037 scopus 로고    scopus 로고
    • Detection of nitrosyl haemoglobin in venous blood in the treatment of sickle cell anaemia with hydroxyurea
    • Glover RE, Ivy ED, Orringer EP, Maeda H, Mason RP. Detection of nitrosyl haemoglobin in venous blood in the treatment of sickle cell anaemia with hydroxyurea. Mol Pharmacol. 1999;55: 1006-1010.
    • (1999) Mol Pharmacol , vol.55 , pp. 1006-1010
    • Glover, R.E.1    Ivy, E.D.2    Orringer, E.P.3    Maeda, H.4    Mason, R.P.5
  • 55
    • 0036175090 scopus 로고    scopus 로고
    • Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease
    • Gladwin MT, Shelhamer JH, Ognibene FP, et al. Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br J Haematol. 2002;116:436-444.
    • (2002) Br J Haematol , vol.116 , pp. 436-444
    • Gladwin, M.T.1    Shelhamer, J.H.2    Ognibene, F.P.3
  • 56
    • 0030464953 scopus 로고    scopus 로고
    • Hydroxyurea and sickle cell anaemia: Clinical utility of a myelosuppressive 'switching' agent: The multicenter study of hydroxyurea in sickle cell anaemia
    • Charache S, Barton FB, Moore RD, et al. Hydroxyurea and sickle cell anaemia: clinical utility of a myelosuppressive 'switching' agent: the multicenter study of hydroxyurea in sickle cell anaemia. Medicine. 1996;75:300-326.
    • (1996) Medicine , vol.75 , pp. 300-326
    • Charache, S.1    Barton, F.B.2    Moore, R.D.3
  • 57
    • 23044442033 scopus 로고    scopus 로고
    • Haematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran
    • Karimi M, Darzi H, Yavarian M. Haematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. J Pediatr Hematol Oncol. 2005;27:380-385.
    • (2005) J Pediatr Hematol Oncol , vol.27 , pp. 380-385
    • Karimi, M.1    Darzi, H.2    Yavarian, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.